Active Shortage

CARBOPLATIN INJECTION

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of CARBOPLATIN INJECTION in Canada?

Yes. CARBOPLATIN INJECTION 10MG has an active shortage reported to Health Canada (last updated July 15, 2021).

Why is CARBOPLATIN INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will CARBOPLATIN INJECTION be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file1 product · 0 same form & route

Affected strength10MG

Report last updated2021-07-15

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

CARBOPLATIN INJECTION BP

PFIZER CANADA ULC

10MG · DIN 02126680

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02125439

Strength

10MG

Dosage Form

LIQUID

Route

INTRAVENOUS

Active Ingredient

CARBOPLATIN

See all CARBOPLATIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2021-07-15

Active Shortage

Disruption of the manufacture of the drug.

2021-04-29

Active Shortage

Disruption of the manufacture of the drug.

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

3.5MG · DIN 02438399

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163